Effect of valdecoxib pretreatment on pain and secondary hyperalgesia: a randomized controlled trial in healthy volunteers
2006

Valdecoxib and Pain Relief

Sample size: 20 publication Evidence: low

Author Information

Author(s): David Burns, Lindsay Hill, Michael Essandoh, Tomasz M Jarzembowski, Gregg H Schuler, Piotr K Janicki

Primary Institution: Pennsylvania State College of Medicine and Milton S. Hershey Medical Center

Hypothesis

Selective COX-2 inhibitors significantly attenuate the central component of sensitization, thereby decreasing the area of secondary hyperalgesia induced by our heat/capsaicin pain model.

Conclusion

A single, oral dose of valdecoxib does not attenuate secondary hyperalgesia induced by heat/capsaicin in healthy volunteers.

Supporting Evidence

  • Valdecoxib did not significantly change the area of secondary hyperalgesia compared to placebo.
  • Pain thresholds for cold and hot stimuli were similar between the valdecoxib and placebo groups.
  • The study was conducted in a double-blind manner to ensure unbiased results.

Takeaway

The study tested if a pain medication called valdecoxib could help reduce pain sensitivity, but it didn't work as hoped.

Methodology

A randomized, double-blind, placebo-controlled, crossover trial with 20 healthy volunteers receiving either valdecoxib or placebo.

Potential Biases

No significant bias risks were reported.

Limitations

The study did not include a positive control to demonstrate internal sensitivity of the test.

Participant Demographics

20 healthy adult volunteers (10 men and 10 women).

Statistical Information

P-Value

0.092

Statistical Significance

p > 0.05

Digital Object Identifier (DOI)

10.1186/1471-2253-6-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication